2024
DOI: 10.1016/j.biopsych.2023.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating Robustness of Brain Stimulation Biomarkers for Depression: A Systematic Review of Magnetic Resonance Imaging and Electroencephalography Studies

Debby Klooster,
Helena Voetterl,
Chris Baeken
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 68 publications
0
2
0
Order By: Relevance
“…These structural changes may be associated with certain symptoms of depression, such as depressed mood, cognitive dysfunction, and difficulty concentrating. 19 Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) have shown 20 that PFC activity may be reduced in depressed patients, particularly in the face of negative stimuli or stressful events. Positron emission tomography showed that depressed patients had lower PFC gray matter volume and cerebral blood flow values, while cerebral blood flow in this region was closely related to depressive symptoms.…”
Section: Abnormal Neural Circuitsmentioning
confidence: 99%
“…These structural changes may be associated with certain symptoms of depression, such as depressed mood, cognitive dysfunction, and difficulty concentrating. 19 Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) have shown 20 that PFC activity may be reduced in depressed patients, particularly in the face of negative stimuli or stressful events. Positron emission tomography showed that depressed patients had lower PFC gray matter volume and cerebral blood flow values, while cerebral blood flow in this region was closely related to depressive symptoms.…”
Section: Abnormal Neural Circuitsmentioning
confidence: 99%
“…The FOOOF algorithm extracts both aperiodic (exponent and offset) and periodic components of the power spectra (center of frequency, bandwidth, power above the aperiodic exponent slope, and total band power). These parameters were extracted for the delta (1-4 Hz), theta (4-7 Hz), alpha (7-12 Hz), beta (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30), and gamma (30-45 Hz) bands. EEG data were converted from time-series data into frequency representations using Welch's method.…”
Section: Eeg Analysismentioning
confidence: 99%
“…While several groups have reported that higher rostral anterior cingulate cortex theta activity at baseline leads to greater improvement in depressive symptoms after both neuromodulatory and pharmacological interventions [24,25], other groups report that theta power is elevated in more severe depression, corresponding to increased treatment resistance [26,27]. However, a recent review of fMRI and EEG biomarkers of depression in response to brain stimulation therapy by Klooster et al [28] ultimately found that taskbased frontal-midline theta activity and individual alpha frequency were the most robust EEG biomarkers. As such, there remains a high degree of uncertainty surrounding the viability of using EEG biomarkers to predict MDD treatment outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…Further, the opaque nature of the deep-learning approach means it is often difficult to interpret which aspects of the data lead to accurate predictions, leaving researchers and clinicians unable to understand how the algorithm discerns responders and non-responders (Squarcina et al, 2021;Van Der Donckt et al, 2022). Given these limitations, a recent review of the literature identified only four potentially robust biomarkers for the prediction of response to non-invasive brain stimulation (two fMRI biomarkers and two EEG biomarkers) (Klooster et al, 2023). However, given the heterogeneity across individuals with depression, and the likely subtle relationship between any baseline marker and treatment response, it may be that single biomarkers will be unable to obtain the predictive accuracy required for clinical implementation.…”
Section: Introductionmentioning
confidence: 99%